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ABSTRACT
Objective: The aims of the current study are (1) to explore the differences in neuropsychiatric
symptoms (NPS) between young-onset dementia (YOD) and late-onset dementia (LOD), and (2) to
investigate whether the possible differences can be attributed to differences in dementia subtype,
gender, psychotropic drug use (PDU), or dementia severity.
Method: Three hundred and eighty-six nursing home (NH) residents with YOD and 350 with LOD were
included. Multilevel modeling was used to compare NPS between the groups . Furthermore, dementia
subtype, gender, PDU, and dementia severity were added to the crude multilevel models to
investigate whether the possible differences in NPS could be attributed to these characteristics.
Results: Higher levels of apathy were found in NH residents with YOD. After the characteristics were
added to the models, also lower levels of verbally agitated behaviors were found in YOD .
Conclusion: We recommend that special attention be paid to interventions targeting apathy in YOD.
Although no differences in other NPS were found, the PDU rates were higher in YOD, suggesting that
the threshold for the use of PDU in the management of NPS is lower. This underscores the need for
appropriate attention to non-pharmacological interventions for the management of NPS in YOD.
KEYWORDS
Young-onset dementia;
nursing home;
neuropsychiatric symptoms;
psychotropic drugs
DUTCH TRIAL REGISTER:
Trial ID NTR5018
Introduction
Young-onset dementia (YOD) is defined as dementia with
symptom onset before the age of 65. In YOD, neuropsychiatric
symptoms (NPS), such as apathy, agitation, aggression, and
hallucinations, are highly prevalent (Mulders et al., 2016;
Mulders, Zuidema, Verhey, & Koopmans, 2014). A recent
Dutch study showed that 90% of nursing home (NH) residents
with YOD had one or more NPS (Mulders et al., 2016). Previous
research in late-onset dementia (LOD) has shown that NPS
often result in negative health outcomes such as a loss of
quality of life (QoL), increased cost of care, and high workload
for the NH staff (Mulders et al., 2016; Murman et al., 2002;
Wetzels, Zuidema, de Jonghe, Verhey, & Koopmans, 2010;
Zwijsen et al., 2014).
People with YOD may have a higher risk of developing NPS
compared to people with LOD. For example, in the YOD NH
population more than half of the residents are male, com-
pared to 20% of the residents in the LOD NH population
(Mulders et al., 2014; Wetzels, Zuidema, Jansen, Verhey, &
Koopmans, 2010). Extreme NPS seem especially likely to occur
in men below the age of 70 years, as these residents are stron-
ger and more vital (Brodaty, Draper, & Low, 2003). Addition-
ally, people with YOD are cared for at home for a longer
period than people with LOD (Bakker et al., 2012). Therefore,
dementia might be more advanced in NH residents with YOD
compared to LOD at the time of institutionalization. Increased
severity of dementia has been linked to more NPS (such as
agitation, aggression, and apathy) in NH residents with YOD
and LOD (Mulders et al., 2016; Zuidema, de Jonghe, Verhey, &
Koopmans, 2009). In addition, frontotemporal dementia (FTD)
is more common in YOD; higher levels of agitation, disinhibi-
tion, and irritability are found in people with FTD than in
those with AD, at least in the community-dwelling population
(de Vugt et al., 2006; Harvey, Skeleton-Robinson, & Rossor,
2003; Mulders et al., 2014; Ratnavalli, Brayne, Dawson, &
Hodges, 2002).
To develop effective treatment and further enhance care
for NH residents with YOD, it is important to gain more insight
into the differences in NPS between NH residents with YOD
and LOD and the specific characteristics of YOD that might
give rise to these possible differences. This insight supports
health care professionals to direct treatment and provide care
that meets the specific care needs of younger nursing home
residents.
There have been a few studies that directly compared rates
of NPS between YOD and LOD. However, these studies did
not take into account the possible influence of psychotropic
drugs, which are often used in the treatment of NPS. Higher
rates of psychotropic drug use (PDU) are found in nursing
home residents with YOD (87%) than in those with LOD (rang-
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ing from 63%–75%) (Aalten, Van Valen, Clare, Kenny, & Ver-
hey, 2005; Mulders et al., 2016; Nijk, Zuidema, & Koopmans,
2009; Wetzels, Zuidema, de Jonghe, Verhey, & Koopmans,
2011). Therefore, a greater decline in NPS due to treatment
with PDU might be expected in YOD. Furthermore, to our
knowledge, all these studies involve people with Alzheimer’s
dementia (AD), while NPS in other common types of demen-
tia in YOD, such as FTD, were not taken into account.
In NPS studies directly comparing young-onset AD (YO-AD)
and late-onset AD (LO-AD), the results suggest less NPS over-
all in people with YO-AD than in those with LO-AD, at least in
a community-dwelling population. For instance, Toyota et al.
(2007) compared NPS between community-dwelling people
with YO-AD and LO-AD and did not find differences regarding
the prevalence of depressive symptoms and anxiety. More-
over, they found fewer delusions and hallucinations as well as
less agitation, disinhibition, and aberrant motor behavior in
YO-AD than in LO-AD. van Vliet et al. (2012) also found lower
incidence and prevalence rates of NPS in community-dwelling
people with YO-AD than in those with LO-AD. In addition,
Mushtaq et al. (2016) found higher levels of delusions, agita-
tion, anxiety, disinhibition and nighttime behavioral distur-
bances in community-dwelling people with LO-AD than in
those with YO-AD. In contrast, the only study to our knowl-
edge comparing NPS in YOD and in LOD NH residents found
higher levels of behavioral symptoms (e.g. waking up at night,
aimless wandering, hiding things) in NH residents with YO-AD
than in residents with LO-AD among people >90 years old
(Hori et al., 2005).
The aims of the current study are (1) to explore the differ-
ences in NPS between two large samples of NH residents with
YOD and LOD, and (2) to investigate whether possible differ-
ences can be attributed to differences in dementia subtype
(Alzheimer’s dementia, vascular dementia, or other subtypes
including FTD), gender, psychotropic drug use (PDU), or
dementia severity.
Methods
Subjects
This retrospective cross-sectional study is part of the Behavior
and Evolution of Young-ONset Dementia part 2 (Beyond-II)
study, a multicenter intervention study aimed at improving
the management of neuropsychiatric symptoms in institution-
alized people with YOD (N = 203 YOD NH residents) (van Dui-
nen-van den IJssel et al., 2017). Additional baseline data were
used from two other longitudinal studies: the Beyond-I study
(N = 185 YOD NH residents) and the ‘Grip on challenging
behavior study’ (N = 362 LOD NH residents) (Mulders et al.,
2014; Zwijsen et al., 2011). These studies used the same
assessment instruments as the Beyond-II study.
In the Netherlands, a large proportion of nursing homes
have YOD special care units (YOD-SCUs) delivering specialized
care for people with YOD. In the YOD group, only YOD-SCUs
participated. Residents in the YOD group were included in
this study if they had a dementia diagnosis with symptom
onset before the age of 65 and had been residing in the YOD-
SCU for at least one month before inclusion. The dementia
diagnosis was established before inclusion in the study
according to the 4th edition of the Diagnostic and Statistical
Manual of Mental Disorders, Text Revision (American
Psychiatric Association, 2000). In the YOD group, internation-
ally accepted criteria for diagnosing dementia subtypes were
used (Gorno-Tempini et al., 2011; McKeith, 2006; McKhann,
Folstein, Katzman, Price, & Standlan, 1984; Rascovsky et al.,
2011; Roman et al., 1993). The diagnosis was retrieved from
the medical file. The exclusion criteria were lack of informed
consent, dementia caused by human immunodeficiency virus
(HIV), traumatic brain injury, Down’s syndrome, Korsakoff syn-
drome, Huntington’s disease, or alcohol-related dementia. In
the Beyond-II study, informed consent was obtained from the
residents’ legal representative and the informed consent rate
was 88%. In the Beyond-I study, the residents or their legal
representatives had the possibility to object to participation,
resulting in a participation rate of 99%. Some YOD-SCUs par-
ticipated in both the Beyond-I and Beyond-II studies. When
residents had the same gender, date of birth, and diagnosis,
one of them was randomly excluded from either the Beyond-I
or Beyond-II sample used in this study to prevent duplicates.
In the LOD group, participating units for people with
dementia (dementia special care units, DSCUs) were recruited
from nursing homes that collaborate with the VU University
Medical Center (Amsterdam) and the Radboud University
Medical Center Nijmegen (Zwijsen et al., 2011). The same
inclusion criteria (other than symptom onset before the age
of 65) as in the YOD sample were applied in this study to
obtain homogenous samples. Additionally, residents in the
LOD group with an age of 70 years or younger were excluded
to diminish the risk of YOD residents being part of the LOD
group. Residents in the YOD group with an age of 70 years of
older were not excluded, because they all had a symptom
onset before the age of 65; therefore, there was no risk that
they were part of the LOD group. In the LOD group, legal rep-
resentatives of the residents had the possibility to object to
participation, resulting in a participation rate of 99%.
Data collection and assessments
The Beyond-I and Beyond-II study protocols were approved
by the Medical Ethics Committee region Arnhem/Nijmegen.
The Grip on challenging behavior study protocol was
approved by the Medical Ethics Review Committee of the VU
University Medical Center. This research project was per-
formed according to the principles of the Declaration of Hel-
sinki (version November 2013, www.wma.net) and is in
agreement with the law regarding medical-scientific research
in humans (WMO). Trained researchers and research assistants
collected the data through structured interviews with the
nursing staff and from the resident’s medical files. Respond-
ents were considered reliable if they were the vocational
nurse specifically assigned to the resident or had regular con-
tact with the resident in the past month.
Outcome measures
Neuropsychiatric symptoms (NPS) were assessed with the
Dutch version of the Neuropsychiatric Inventory-Nursing
Home Version (NPI-NH). The NPI-NH has high interrater reli-
ability and has been found to be a valid instrument for the
assessment of a wide range of NPS in dementia (Kat et al.,
2002; Kaufer et al., 2000). The NPI-NH consists of ten neuro-
psychiatric symptoms (delusions, hallucinations, agitation/
aggression, depression, anxiety, euphoria/elation, apathy/
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indifference, disinhibition, irritability/lability, aberrant motor
behavior) and two neurovegetative symptoms (nighttime
behavior disturbances and appetite/eating disturbances). For
each symptom, a screening question is used to determine
whether the symptom is present. If the symptom is present,
Frequency (F) and Severity (S) are rated on a four-point (rang-
ing from 1 to 4) and three-point Likert-scale (ranging from 1
to 3), respectively, for each symptom. Scores for each symp-
tom are calculated as F £ S. We were interested in all NPS,
including symptoms with a low frequency or severity and also
when symptoms were not present. Therefore, we also
included symptoms with a low frequency and severity in our
analyses (instead of focusing on only clinical relevant behav-
ior F £ S  4) and chose to score F £ S as 0 when a symptom
was not present. A total score is calculated by summing the F
£ S scores (ranging from 0 to 144). Five NPI-NH factor scores
were calculated by summing the symptom scores (F £ S)
included in each factor: (1) agitation/aggression, consisting of
the agitation/aggression, euphoria, disinhibition and irritabil-
ity symptom scores; (2) depression, consisting of the depres-
sion and anxiety symptom scores; (3) psychosis, consisting of
the delusion and hallucination symptom scores; (4) psycho-
motor agitation, consisting of the aberrant motor behavior
and nighttime behavior symptom scores; and (5) apathy, con-
sisting of the apathy and eating disorder symptom scores.
These neuropsychiatric factors have been found to be rela-
tively consistent in nursing home residents with dementia,
across different stages of dementia (Zuidema, de Jonghe, Ver-
hey, & Koopmans, 2007a).
The Dutch version of the Cohen-Mansfield Agitation Inven-
tory (CMAI-D) was used to assess agitation and aggression
(Cohen-Mansfield & Billig, 1986; de Jonghe & Kat, 1996). The
CMAI has well-established validity and reliability and assesses
29 agitated or aggressive behaviors (de Jonghe & Kat, 1996).
The frequency of each symptom is rated on a seven-point
scale (range 1–7) ranging from never to several times an hour.
The total CMAI score ranges from 29 to 203. We used CMAI
factors based on a previous study in which three CMAI factors
in a large NH sample were found: physically non-aggressive
behaviors (range 7–49), physically aggressive behaviors
(range 8–56), and verbally agitated behaviors (range 4–28)
(Zuidema, de Jonghe, Verhey, & Koopmans, 2007b).
Other measures
Dementia severity was assessed with the Global Deterioration
Scale (GDS) (Reisberg, Ferris, de Leon, & Crook, 1982). The
GDS describes seven different stages of dementia on a seven-
point scale (1–7), ranging from ‘subjectively and objectively
normal cognition’ to ‘severe cognitive decline.’ The GDS has
been validated against behavioral, neuro-anatomical and neu-
rophysiological measures, for which significant correlations
were found (Reisberg et al., 1982).
In addition, data on dementia subtype, age, gender and
length of stay at the YOD-SCU or DSCU were collected from
resident’s medical files. Psychotropic drug use (PDU) was
derived from the nursing homes pharmacists’ electronic files
and was classified according to the Anatomical Therapeutic
Chemical (ATC) classification system (World Health Organisa-
tion Collaborating Centre for Drug Statistics Methodology,
1997) into antipsychotics, anxiolytics, hypnotics, antidepres-
sants, anti-epileptics, anti-dementia drugs, and any psychotro-
pic medication.
Statistical analysis
All analyses were performed using Statistical Package for the
Social Sciences (SPSS) version 22. Before analysis, the data
were checked for missing values. If the proportion of missing
values in the CMAI total and factor scores was 20% or less, the
missing items were replaced with the mean of the remaining
items. It was not possible to use mean imputation on the NPI-
NH factor scores, GDS, or PDU, as these scores consisted of
less than 5 items, and even a single missing value would con-
stitute more than 20% of the items. Therefore, residents with
missing items on the NPI-NH symptom scores, GDS, and PDU
were excluded from analysis.
Demographic variables for both groups (LOD and YOD)
were described by calculating means or proportions. Multi-
level modeling (random intercept linear mixed models) was
used to compare the mean CMAI total, CMAI factor (physically
aggressive behaviors, physically nonaggressive behaviors, ver-
bally agitated behaviors), NPI-NH total, and NPI-NH factor (agi-
tation, depression, psychosis, psychomotor agitation, apathy)
scores as dependent variables, with group (YOD versus LOD)
as an independent variable. Multilevel modeling allows cor-
rection for the clustering of residents in different health care
organizations and therefore also for possible differences in
cohorts as each health care organization was part of a specific
cohort. Furthermore, to investigate whether the possible dif-
ferences could be attributed to differences in dementia sub-
type (Alzheimer’s dementia, vascular dementia, or other
subtypes including FTD), gender, psychotropic drug use
(using dichotomous categories: present or absent), or demen-
tia severity (GDS: mild, moderate, severe), we added these
variables to the crude multilevel models.
Results
Resident characteristics
A total of 736 residents were included, of whom 386 residents
had YOD and 350 had LOD. In the YOD group, the ratio of
males to females was approximately equal (49.5% female), in
contrast to the LOD group, in which a large majority of sub-
jects were female (73.7%). In both the YOD and LOD group,
most residents had Alzheimer’s dementia (43.3% in YOD and
48.6% in LOD). The second most prevalent dementia subtype
was vascular dementia (35.1%) in the LOD group and fronto-
temporal dementia (FTD) (25.1%) in the YOD group. In both
YOD and LOD, most residents had advanced dementia (62.7%
in YOD and 76.8% in LOD). Furthermore, psychotropic drug
use (PDU) seemed more common in the YOD group (76.9% in
YOD versus 55.1% in LOD) (Table 1).
Differences in NPS between YOD and LOD
The unadjusted multilevel models showed that residents with
YOD had higher mean NPI-NH apathy factor scores than resi-
dents with LOD (p < .001, B = 2.612) (Table 2, model 1). No
other statistically significant differences were found on either
the NPI-NH or the CMAI factor scores. After entry of PDU, gen-
der, dementia severity and dementia subtype into the multi-
level models, significant differences in both the apathy score
(p < .001 B = 2.794) and the mean CMAI verbally agitated
behaviors factor score were found (p = .023, B = ¡1.403)
(Table 2, model 2). Residents with YOD had lower mean CMAI
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verbally agitated behaviors factor scores compared to resi-
dents with LOD.
Discussion
In this study, the differences in NPS between heterogeneous
samples of nursing home (NH) residents with YOD and LOD
were investigated. Higher levels of apathy were found in NH
residents with YOD compared to LOD. Furthermore, after cor-
rections were applied for gender, PDU, GDS, and dementia
subtype, higher levels of verbally agitated behaviors were
found in LOD than in YOD.
In line with our findings, Cohen-Mansfield and Libin (2005)
found that higher levels of verbal agitation were associated
with older age. An explanation could be that with advanced
age, more physical impairments are likely to occur, hindering
activities in daily life. This likely results in feelings of frustration
and a consequent increase in verbally agitated behaviors in
response to the high levels of physical impairment. Higher
rates of verbal aggression in LOD were only found in our
study after taking into account the influence of possible con-
founders (gender, PDU, dementia subtype, dementia severity).
An explanation could be the higher prevalence of residents
with less advanced dementia in the YOD group, as verbally
agitated behavior is less prevalent in advanced dementia
(Mulders et al., 2016). Furthermore, we did not find differen-
ces in the CMAI total or other factor scores, which supports
the notion that agitation is a multidimensional construct con-
sisting of different aspects that should be taken into account
in further research in order to prevent loss of information.
Table 1. Demographic and clinical characteristics of the YOD and LOD group.
YOD
N = 386
LOD
N = 350
Resident age at inclusion Mean (SDa) 62.4 (6.9) 84.43 (6.3)
(Range) (39–78) (71–102)
Resident gender Male n (%) 195 (50.5) 92 (26.3)
Dementia severity (GDSb)c n (%)
Mild (2,3,4) 62 (16.1) 13 (3.7)
Moderate (5) 81 (21.0) 66 (18.9)
Severe (6,7) 242 (62.7) 267 (76.3)
Dementia subtype n (%)
Alzheimer’s disease 167 (43.3) 170 (48.6)
Vascular dementia 56 (14.5) 123 (35.1)
Frontotemporal dementia 97 (25.1) 7 (2.0)
Other 66 (17.1) 50 (14.3)
PDUd (at least one)e n (%) 297 (76.9) 193 (55.1)
CMAIf total score Mean (SD) 49.60 (18.37) 50.55 (18.21)
CMAI factor scoresg Mean (SD)
Physically aggressive behaviors 13.55 (6.51) 13.88 (6.36)
Physically nonaggressive behaviors 14.38 (7.97) 13.87 (7.72)
Verbally agitated behaviors 8.37 (5.99) 9.24 (5.96)
NPI-NHh total score Mean (SD) 22.84 (17.77) 21.22 (17.80)
NPI-NH factor scores Mean (SD)
Agitation 9.93 (10.21) 9.96 (9.65)
Depression 3.11 (5.17) 4.12 (5.31)
Psychosis 1.79 (3.92) 2.26 (4.37)
Psychomotor agitation 4.84 (6.22) 3.97 (5.47)
Apathy 5.95 (5.97) 3.46 (4.96)
a SD = standard deviation.
b GDS = Global Deterioration Scale.
c 1 missing in YOD group, 4 missing in LOD group.
d PDU = Psychotropic drug use.
e 8 missing in LOD group.
f CMAI = Cohen-Mansfield Agitation Inventory.
g 1 missing in YOD group, 6 missing in LOD group.
h NPI-NH = Neuropsychiatric Inventory-nursing home version.
Table 2. Multilevel models with differences between groups (YOD/LOD) on NPS with no correction (Model 1), and correction for gender, PDU, dementia severity,
and dementia subtype (Model 2).
Model 1 Model 2
95% CI 95% CI
B P Lower bound Upper bound B P Lower bound Upper bound
CMAI total score –.316 .900 –5.386 4.753 –1.480 .544 –6.365 3.406
CMAI factor scores
Physically aggressive behaviors –.236 .766 –1.833 1.361 –.234 .751 –1.711 1.243
Physically nonaggressive behaviors .761 .440 –1.22 2.743 .426 .673 –1.510 2.451
Verbally agitated behaviors –.827 .115 –1.865 .211 –1.403 .023* –2.600 –.206
NPI-NH total score 2.047 .342 –2.271 6.364 1.597 .444 –2.573 5.766
NPI-NH factor scores
Agitation/aggression .061 .943 –1.658 1.780 –1.002 .270 –2.478 1.036
Depression –.972 .117 –2.201 .258 –.710 .221 –1.866 .446
Psychosis –.419 .387 –1.393 .555 –.490 .341 –1.519 .539
Psychomotor agitation .988 .143 –.349 2.324 .708 .335 –.761 2.178
Apathy 2.612 .000** 1.251 3.972 2.794 .000** 1.502 4.086
Note: CMAI = Cohen-Mansfield Agitation Inventory; NPI-NH = Neuropsychiatric Inventory-nursing home version.
PDU = Psychotropic drug use.
*<.05.
**<.01.
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We found higher levels of apathy in NH residents with YOD
than in those with LOD. This might be partly explained by the
high prevalence in YOD of FTD, in which higher rates of apa-
thy have been found compared to AD (de Vugt et al., 2006).
However, these differences were still strongly significant after
dementia subtype was corrected for, suggesting that higher
rates of apathy exist in NH residents with YOD, irrespectively
of dementia subtype. Another explanation might be that the
frequency and severity of the NPS (including apathy) were
rated by nursing staff members. Nurses might observe apathy
in LOD less often because they might perceive the inactivity
as part of older age. Although apathy is often not experienced
as disturbing by nursing staff, the higher rates found in NH
residents with YOD still raise concern because of the strong
negative association between apathy and quality of life in NH
residents with YOD (Appelhof et al., 2017; Zwijsen et al.,
2014). Therefore, special attention needs to be directed to
interventions targeting apathy in NH residents with YOD.
Although we did not find any additional differences in NPS
between the two groups, the PDU rates in YOD seemed
higher than those of the LOD group (77% in YOD versus 55%
in LOD). This suggests that the threshold for the use of psy-
chotropic drugs in the management of NPS is lower in YOD.
An explanation for the higher levels of PDU in YOD could be
that the same behaviors in younger individuals are perceived
as more threatening or distressing by the nursing staff. Conse-
quently, physicians might be more inclined to prescribe psy-
chotropic drugs in YOD than in LOD (Zuidema, de Jonghe,
Verhey, & Koopmans, 2011). In future studies, further testing
is needed on differences in distress experienced by YOD and
LOD nursing staff in response to residents’ NPS.
Several limitations of this study should be considered. We
chose to use factor scores instead of symptom scores on the
NPI-NH in order to reduce the number of tests in the analyses
and thereby diminish the risk of a Type 1 error. Additionally,
we used factor scores of the CMAI instead of the total score to
provide clarity regarding the possible differences in specific
aspects of aggression and thereby prevent a loss of informa-
tion. However, the factor structure of both the NPI-NH and
CMAI was evaluated in older NH residents with dementia and
has not yet been established in YOD (Zuidema et al., 2007a,
2007b). Furthermore, part of the YOD group was drawn from
an older cohort. There is a possibility that there are differences
within these cohorts (for example, due to changes in the
health care system), for which we partly corrected with the
use of the multi-level models. At last, we cannot confirm that
the international accepted criteria for diagnosing dementia
subtypes were used in all residents part of the LOD group.
Conclusion
This study provides important insight into the differences in
NPS between NH residents with YOD and LOD. The higher
rates of apathy found in NH residents with YOD raise concern
because of the strong negative association between apathy
and quality of life (Appelhof et al., 2017). Therefore, in order
to improve care, we recommend that special attention be
paid to interventions targeting apathy in NH residents with
YOD. For example, especially for nursing home residents with
YOD, it might be important to provide a stimulating socio-
therapeutic environment and approach to facilitate social
engagement and activities of daily living. Further research is
needed to gain insight into possible biological or psychosocial
influences underlying the differences in apathy between nurs-
ing home residents with YOD and LOD.
Although NH residents with YOD were no more likely than
those with LOD to develop NPS other than apathy, residents
with YOD still received psychotropic drugs more often in the
treatment of NPS. This underscores the need for appropriate
attention to effective non-pharmacological interventions for
the management of NPS in YOD.
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